This one-year Master of Science (M.Sc.) program in Translational Oncology focuses on the cellular and molecular foundations of cancer. It is designed for scientists, clinicians, and healthcare professionals seeking an in-depth understanding of cancer's causes, progression, and treatment. The course covers the scientific and clinical challenges associated with managing various cancers, from conventional therapies to personalized molecular and immune-based treatments. Trinity College Dublin, with its strong cancer research base and links to teaching hospitals like St. James's Hospital, offers a comprehensive curriculum addressing the rising global cancer incidence and the critical need for advanced research.
The program consists of eleven taught modules and a 12-week research project. Lectures and tutorials are scheduled primarily during weekdays, with potential adjustments to accommodate visiting lecturers. Research skills modules run throughout the second semester, leading into the full-time research project.
Graduates are well-regarded by academic and industry partners, with over 92% securing employment in the last four years. The program prepares students for diverse career paths in oncology.
All applicants must provide two academic or clinical references and a 500-word personal statement detailing their interest and suitability for the program.
Fees are subject to annual review. In addition to tuition, students must pay a Student Contribution Fee (for undergraduate EU students only) and Student Levies and Charges.
You need a minimum upper second-class (2.1) honours degree in science, medicine, or a related discipline, or an M.B., B.Ch., B.A.O. or equivalent from a recognised medical school.
You will need to submit academic transcripts, a CV, two academic or clinical references, and a 500-word personal statement explaining your interest and suitability for the program.
The application closing date is 31 July 2026 for the September 2026 intake.
The program is one year in duration, consisting of eleven taught modules and a 12-week research project.
Over 92% of graduates have secured employment in the last four years, with career paths including further research (including PhD), hospital positions, and roles in pharmaceutical or clinical trial companies.
Tuition fees are subject to change and are listed on the Postgraduate Fees page of the university website; specific figures are not provided within the program details.